1-1 of 1
Wenyuan Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of HPB-092: A novel dual kinase inhibitor targeting FLT3 and IRAK4 for the treatment of relapsed/refractory Acute Myeloid Leukemia (RR-AML)

Free
Yong Guo, He Zhou, Bing Zhang, Rui Yang, Danqiu Lin, Lei Wu, Wenyuan Xu, Michael Xiang, Suyue Wang, Camille Xiang, Lan Xu, Jason Xiang
Journal: Blood
Blood (2025) 146 (Supplement 1): 6948.
https://doi.org/10.1182/blood-2025-6948
Published: 2025